Bayh-Dole
Fabrazyme March-In Request
Submitted by James Love on 2. August 2010 - 12:37New: NIH rejects Fabrazyme March-In Petition
- December 7, 2010. Press release from Fabry patients: DHHS denies patient’s march-in request to end Genzyme’s rationing of treatment for Fabry Disease citing that FDA rules block manufactures from supplying the drug in a timely manner.
- December 7, 2010. Statements by KEI and others on NIH rejection of Fabrazyme March-In Request
Statutes mentioned in 35 USC 210 of the Bayh-Dole Act
Submitted by James Love on 31. July 2010 - 22:00When the Bayh-Dole Act was passed in 1980, it included a provision that identified 21 statutes over which the Act would take precedence. I have reordered them according to dates they appear to have been enacted, and provided some details of the referenced statutes.
35 U.S.C. 210 Precedence of chapter.
Bayh-Dole Timeline
For more information, KEI general website on the Bayh Dole Act
TIMELINE
1980
On December 12, 1980, P.L. 96-517, the Bayh-Dole Act was enacted into law. It is codified in 35 U.S.C. § 200-212
The Stevenson-Wydler Acts is enacted into law
1981
The Bayh-Dole Act became effective on July 1, 1981
1982
The Bayh-Dole Act of 1980
The Bayh-Dole Act (or University and Small Business Patent Procedures Act) was originally enacted in 1980 as Public Law 96-517, and was amended in 1984 by Public Law 98-620. Among other things, the Bayh-Dole Act was designed to facilitate the patenting of U.S. government funded inventions by universities, other non-profit entities and businesses.
